Profiel
P.
Martin Petkovich was the founder of Cytochroma, Inc. which was founded in 1996, where he held the title of Chief Scientific Officer from 2009 to 2012.
He also worked as a Principal at Queen's University.
Dr. Petkovich earned a doctorate degree from the University of Toronto in 1986 and an undergraduate degree from McMaster University in 1981.
Eerdere bekende functies van P. Martin Petkovich
| Bedrijven | Functie | Einde |
|---|---|---|
| Queen's University | Corporate Officer/Principal | - |
Cytochroma, Inc.
 Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Oprichter | - |
Opleiding van P. Martin Petkovich
| McMaster University | Undergraduate Degree |
| University of Toronto | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Cytochroma, Inc.
Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |
